Lilly says science and technology head will retire, to be replaced by AstraZeneca counterpart Eli Lilly & Co. said Friday its science and ...
GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly & Co., making a two-year-old partnership official ...
FILE - In this Jan 25, 2006 file photo, The Eli Lilly and Company headquarters in pictured in Indianapolis. Drugmaker Eli Lilly & Co. said Monday, Sept. 14, 2009, that it will eliminate 5,500 jobs, or nearly 14 percent of its staff, ...
US pharmaceutical group Eli Lilly will trim more than 5,000 jobs worldwide by the end of 2011 as part of a broad restructuring plan that also aims to speed up development of key medicines. The action will reduce the global workforce from ...
Drugmaker Eli Lilly & Co. says it will eliminate thousands of jobs and reorganize into five business units in an effort to slash costs and speed up development of potential new drugs. The Indianapolis company says it will reduce its work force ...
Dyax receives $1.5 million payment as partner Eli Lilly's ImClone moves drug into development Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly & Co. moved a potential leukemia treatment into early-stage clinical trials. The payment, ...
Amgen (AMGN) and Eli Lilly (LLY) have endured some tough news in recent days on their experimental osteoporosis drugs. The companies' reactions provide investors with a clear picture of how pharmaceutical firms are adjusting their approaches to research and development in the ...
Eli Lilly will not ask for approval of osteoporosis drug based on study data, safety concerns Eli Lilly & Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal osteoporosis drug because of certain study results ...
